Interim Results of a Phase 1/2 Open‐Label Study of INO‐3107 for HPV‐6 and/or HPV‐11‐Associated Recurrent Respiratory Papillomatosis

Objective To evaluate the safety, immunogenicity, and efficacy of INO‐3107, a DNA immunotherapy designed to elicit targeted T‐cell responses against human papillomavirus (HPV) types 6 and 11, in adult patients with recurrent respiratory papillomatosis (RRP; NCT04398433). Methods Eligible patients re...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Laryngoscope 2023-11, Vol.133 (11), p.3087-3093
Hauptverfasser:	Mau, Ted, Amin, Milan R., Belafsky, Peter C., Best, Simon R., Friedman, Aaron D., Klein, Adam M., Lott, David G., Paniello, Randal C., Pransky, Seth M., Saba, Nabil F., Howard, Tamara, Dallas, Michael, Patel, Aditya, Morrow, Matthew P., Skolnik, Jeffrey M.
Format:	Artikel
Sprache:	eng
Schlagworte:	DNA immunotherapy electroporation HPV‐6/HPV‐11 Human papillomavirus INO‐3107 recurrent respiratory papillomatosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!